文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

追踪脊髓灰质炎根除进展的监测——全球,2020-2021年

Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-04-15

本报告总结了2020和2021年43个优先国家的急性弛缓性麻痹(AFP)监测绩效指标。2021年有32个(74%)优先国家在国家层面达到两项关键监测绩效指标目标,较2020年的23个(53%)有所改善,但国家和次国家层面仍存在显著差距。高质量的脊髓灰质炎病毒监测对追踪病毒传播至关重要。

要点

  • 2021年32个(74%)优先国家达到两项关键监测指标目标,2020年为23个(53%)。
  • 2020年1-9月AFP报告病例数下降,粪便标本采集至实验室接收间隔较2019年同期增加。
  • 2020-2021年31个国家报告了循环疫苗衍生脊髓灰质炎病毒(cVDPV)病例。

核心结论

  • 2021年达到两项关键监测绩效指标目标的优先国家比例较2020年有所改善,但国家和次国家层面仍存在显著差距。
  • 高质量的脊髓灰质炎病毒监测对追踪病毒传播至关重要,频繁监测监测指标有助于识别差距、指导改进并提高检测的敏感性和及时性。

研究设计与样本

  • 本报告总结了2020和2021年43个优先国家的脊髓灰质炎监测绩效指标,更新了既往报告。

主要发现

  • 2021年,43个优先国家中有32个(74%)在国家层面达到两项关键监测绩效指标目标,而2020年仅有23个(53%)达到两项目标。
  • 2020年1-9月,报告的AFP病例数下降,且粪便标本采集至实验室接收的间隔较2019年同期增加。
  • 2020-2021年,31个国家报告了cVDPV病例。
  • 2021年报告了一例WPV1病例,发病时间为2021年,由马拉维报告,此距世界卫生组织非洲区域被认证为无WPV已过去一年。

临床怎么用

  • 通过监测年龄<15岁人群的急性弛缓性麻痹(AFP)病例,并经WHO认证实验室的粪便标本检测确认,是检测脊髓灰质炎病毒传播的主要手段,辅以对污水的系统采样和脊髓灰质炎病毒检测(环境监测)。

局限性

  • 2020年COVID-19大流行导致WHO各区域的脊髓灰质炎疫苗接种和监测活动受到干扰。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of reported poliomyelitis cases worldwide has declined by approximately 99.99%. By the end of 2021, wild poliovirus (WPV) remained endemic in only two countries (Pakistan and Afghanistan). However, a WPV type 1 (WPV1) case with paralysis onset in 2021, was reported by Malawi a year after the World Health Organization (WHO) African Region (AFR) was certified as WPV-free and circulating vaccine-derived poliovirus (cVDPV) cases were reported from 31 countries during 2020-2021 (1,2). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity and cause paralysis. The primary means of detecting poliovirus transmission is through surveillance for acute flaccid paralysis (AFP) among persons aged <15 years, with confirmation through stool specimen testing by WHO-accredited laboratories, supplemented by systematic sampling of sewage and testing for the presence of poliovirus (environmental surveillance). The COVID-19 pandemic caused disruptions in polio vaccination and surveillance activities across WHO regions in 2020; during January-September 2020, the number of reported cases of AFP declined and the interval between stool collection and receipt by laboratories increased compared with the same period in 2019 (3). This report summarizes surveillance performance indicators for 2020 and 2021 in 43 priority countries* and updates previous reports (4). In 2021, a total of 32 (74%) priority countries† met two key surveillance performance indicator targets nationally, an improvement from 2020 when only 23 (53%) met both targets; however, substantial national and subnational gaps persist. High-performing poliovirus surveillance is critical to tracking poliovirus transmission. Frequent monitoring of surveillance indicators could help identify gaps, guide improvements, and enhance the overall sensitivity and timelines of poliovirus detection to successfully achieve polio eradication.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Wilkinson AL, Diop OM, Jorba J, et al. Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35421079. doi:10.15585/mmwr.mm7115a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。